Celcuity Inc., a cellular analysis company, discovers cancer sub-types and commercializes diagnostic tests to enhance the response rates of cancer patients treated with targeted therapies in the United States. The company is developing CELx tests to diagnose two new sub-types of HER2-negative breast cancer. It is also developing CELx tests to diagnose 14 new potential cancer sub-types in breast, lung, colon, ovarian, kidney, bladder, and hematological cancers. The company was founded in 2012 and is headquartered in Minneapolis, Minnesota.
Industry, Sector and Symbol
Industry Medical laboratories
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:CELC
CUSIPN/A
Phone763-392-0767
Debt
Debt-to-Equity RatioN/A
Current Ratio29.90
Quick Ratio29.90
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book Value$3.11 per share
Price / Book7.89
Profitability
EPS (Most Recent Fiscal Year)N/A
Net Income$-6,250,000.00
Net MarginsN/A
Return on Equity-28.28%
Return on Assets-25.90%
Miscellaneous
Employees22
Outstanding Shares10,110,000
Celcuity (NASDAQ:CELC) Frequently Asked Questions
What is Celcuity's stock symbol?
Celcuity trades on the NASDAQ under the ticker symbol "CELC."
How were Celcuity's earnings last quarter?
Celcuity Inc (NASDAQ:CELC) announced its quarterly earnings results on Monday, May, 14th. The company reported ($0.19) EPS for the quarter. View Celcuity's Earnings History.
Who are some of Celcuity's key competitors?
Some companies that are related to Celcuity include Natera (NTRA), RadNet (RDNT), InVitae (NVTA), CareDx (CDNA), Veracyte (VCYT), Enzo Biochem (ENZ), PotNetwork (POTN), Miragen Therapeutics (MGEN), Psychemedics (PMD), Fulgent Genetics (FLGT), First Choice Healthcare Solutions (FCHS), Cancer Genetics (CGIX), Biocept (BIOC), OpGen (OPGN) and CBA Florida (CBAI).
Who are Celcuity's key executives?
Celcuity's management team includes the folowing people:
- Mr. Brian F. Sullivan, Co-Founder, Chairman, CEO & CFO (Age 56)
- Dr. Lance G. Laing, Co-Founder, Chief Science Officer, VP, Sec. & Director (Age 56)
- Ms. Vicky Hahne, Chief Financial Officer (Age 52)
- Ms. Laura Beggrow RN, Chief Commercial Officer (Age 55)
- Mr. Larry Fitzgerald, VP of Strategic Partnerships & Managed Markets (Age 47)
When did Celcuity IPO?
(CELC) raised $18 million in an initial public offering (IPO) on Wednesday, September 20th 2017. The company issued 2,000,000 shares at a price of $8.00-$10.00 per share. Craig-Hallum Capital Group acted as the underwriter for the IPO.
Has Celcuity been receiving favorable news coverage?
Press coverage about CELC stock has trended somewhat positive on Sunday, according to Accern Sentiment. The research firm ranks the sentiment of press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Celcuity earned a media sentiment score of 0.03 on Accern's scale. They also assigned news articles about the company an impact score of 45.27 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next few days.
Who are Celcuity's major shareholders?
Celcuity's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Gagnon Securities LLC (2.07%), ARS Investment Partners LLC (1.31%), BlackRock Inc. (1.26%), Park West Asset Management LLC (0.80%), Northern Trust Corp (0.21%) and Punch & Associates Investment Management Inc. (0.13%). View Institutional Ownership Trends for Celcuity.
Which major investors are selling Celcuity stock?
Which major investors are buying Celcuity stock?
CELC stock was bought by a variety of institutional investors in the last quarter, including ARS Investment Partners LLC, Punch & Associates Investment Management Inc., Northern Trust Corp and BlackRock Inc.. View Insider Buying and Selling for Celcuity.
How do I buy shares of Celcuity?
Shares of CELC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Celcuity's stock price today?
One share of CELC stock can currently be purchased for approximately $24.55.
How big of a company is Celcuity?
Celcuity has a market capitalization of $217.60 million. Celcuity employs 22 workers across the globe.
How can I contact Celcuity?
Celcuity's mailing address is 16305 36TH AVENUE N SUITE 450, MINNEAPOLIS MN, 55446. The company can be reached via phone at 763-392-0767.
MarketBeat Community Rating for Celcuity (CELC)
MarketBeat's community ratings are surveys of what our community members think about Celcuity and other stocks. Vote "Outperform" if you believe CELC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CELC will underperform the S&P 500 over the long term. You may vote once every thirty days.
